Product Information

OXCARBAZEPINE 150 MG TABLET is a generic product labeled by Breckenridge Pharmaceutical Inc., priced at $0.1085 per EA under NDC 51991005301. Its NADAC has been published 67 times since Aug 13, 2025.

FDA first approved this application on Jan 11, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OXCARBAZEPINE 150 MG TABLET

OXCARBAZEPINE
$0.1085per EA

Strength

150 mg/1

NDC

51991005301

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

OXCARBAZEPINE

Approval Type

Generic (ANDA)

FDA Application

ANDA078069

FDA Approved

1/11/2008

TE Code

AB

On Market Since

1/11/2008

Pharmacological Classes

Anti-epileptic Agent
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for OXCARBAZEPINE 150 MG TABLET has been published 67 times since Aug 13, 2025, and over the history we have for it it has declined 8.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1085 per EA
All-time high$0.1187 (Aug 13, 2025)
All-time low$0.1036 (Jun 17, 2026)
52-week high$0.1160
52-week low$0.1036
Median price$0.1072
Average price$0.1098
Largest weekly change-3.4% (Jun 17, 2026)
Weeks tracked67
Tracking sinceAug 13, 2025

Price History

1W

+1.7%

1M

+2.1%

3M

+4.6%

6M

+1.3%

1Y

-6.5%

3Y

N/A

5Y

N/A

All

-8.6%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of OXCARBAZEPINE 150 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for OXCARBAZEPINE 150 MG TABLET, manufactured by Breckenridge Pharmaceutical Inc., is $0.1085 per EA (NDC 51991005301), effective Nov 18, 2026.

How has the price of OXCARBAZEPINE 150 MG TABLET changed over time?

Over the history we have for it, the NADAC for OXCARBAZEPINE 150 MG TABLET has declined 8.6%. It has been tracked across 67 weekly CMS publications since Aug 13, 2025.

What are the highest and lowest recorded NADAC prices for OXCARBAZEPINE 150 MG TABLET?

Since Aug 13, 2025, the NADAC for OXCARBAZEPINE 150 MG TABLET has ranged from a low of $0.1036 (Jun 17, 2026) to a high of $0.1187 (Aug 13, 2025), with a median of $0.1072 per EA.

Are there cheaper alternatives to OXCARBAZEPINE 150 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OXCARBAZEPINE 150 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures OXCARBAZEPINE 150 MG TABLET?

OXCARBAZEPINE 150 MG TABLET (NDC 51991005301) is labeled by Breckenridge Pharmaceutical Inc., and CMS classifies it as a generic product.